Tivic Health appoints interim CFO Kimberly Bambach, strategic advisor Christina Valauri; CFO Veronica Cai resigns

Valion Bio, Inc.

CFO Veronica Cai resigned effective April 28, 2023; receives $125K lump sum upon signing release.
Kimberly Bambach appointed interim CFO, paid $200/hour as non-employee consultant.
Christina Valauri engaged as strategic advisor to board; former healthcare analyst at Cantor Fitzgerald.
Cai stated resignation not due to any disagreement with company's operations or policies.
Bambach brings 30+ years financial leadership; previously CFO of Jushi Holdings.

item 1.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Kimberly Bambach

interim Chief Financial Officer and Principal Financial and Principal Accounting Officer

VBIO · Valion Bio, Inc.

Effective: 2023-04-28
Filed: May 1, 2023, 7:59 PM ET

Effective April 28, 2023, Kimberly Bambach was appointed as the Company’s new interim Chief Financial Officer and Principal Financial and Principal Accounting Officer.

Departed

Veronica Cai

Chief Financial Officer

VBIO · Valion Bio, Inc.

Effective: 2023-04-28
Successor: Kimberly Bambach
Filed: May 1, 2023, 7:59 PM ET

On April 28, 2023, Veronica Cai resigned from her role as Chief Financial Officer of Tivic Health Systems, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kimberly Bambach was appointed as interim Chief Financial Officer and Principal Financial and Principal Accounting Officer at Valion Bio, Inc..

Action: appointed
Role: interim Chief Financial Officer and Principal Financial and Principal Accounting Officer

Exact text from the filing

Effective April 28, 2023, Kimberly Bambach was appointed as the Company’s new interim Chief Financial Officer and Principal Financial and Principal Accounting Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Veronica Cai resigned as Chief Financial Officer at Valion Bio, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On April 28, 2023, Veronica Cai resigned from her role as Chief Financial Officer of Tivic Health Systems, Inc.

View on SEC.gov

Valion Bio, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-016054

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.